Status:
COMPLETED
Walnuts to Achieve Lasting NUTrition to Prevent Diabetes
Lead Sponsor:
University of California, San Francisco
Conditions:
PreDiabetes
Overweight and Obesity
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Prediabetes is a precursor of type 2 diabetes and an independent risk factor for cardiovascular disease, and currently affects one-quarter of the population of the United States. Individuals of overwe...
Eligibility Criteria
Inclusion
- Male or female between 18-65 years of age at baseline living in the San Francisco Bay area.
- BMI\>25 m/kg2 (or \>23 m/kg2 for individuals of Asian or South Asian ethnicity)
- Documentation of prediabetes diagnosis as evidenced by the following criteria:
- A fasting glucose 100-125 mg/dL, or a HbA1c measurement of 5.7-6.4%, OR a diagnosis of "prediabetes" or "impaired fasting glucose" in the past 6 months, identified through an electronic medical record query from patients at UCSF and through outside recruitment in the surrounding community
- We will confirm eligibility of potential participants by repeating fasting capillary blood glucose measurements at the baseline visit to ensure that they have prediabetes
- Written informed consent and ability for subject to comply with the requirements of the study.
Exclusion
- Pregnant or breastfeeding women at enrollment.
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data, such as diverticulosis or diverticulitis.
- Tree or peanut allergies
- Unwilling to consume a daily walnut supplement.
- Diagnosis of diabetes
- On glucose lowering medications
- Dietician-managed dietary intake, or personal or medical dietary restrictions that do not allow consumption of walnuts
- Malabsorptive conditions including intestinal bypass surgery, pancreatitis, inflammatory bowel disease
Key Trial Info
Start Date :
May 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03334175
Start Date
May 21 2018
End Date
August 5 2019
Last Update
September 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143